Melvin Spigelman
- Infectious Diseases top 0.5%
- Epidemiology top 1%
- Molecular Biology top 10%
- Surgery top 5%
- Molecular Medicine top 1%
- Co-authors
- Ann M. GinsbergCarl M. MendelChristo van NiekerkDaniel E. EverittKeertan DhedaMario RaviǵlioneMarcel A. BehrHaileyesus Getahun
- Topics
- Tuberculosis Research and Epidemiology (22 papers)Mycobacterium research and diagnosis (7 papers)Pneumocystis jirovecii pneumonia detection and treatment (6 papers)
- Partner nations
- United StatesUnited KingdomSouth Africa
In The Last Decade
Melvin Spigelman
42 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Infectious Diseases 2.6k
- Epidemiology 1.8k
- Molecular Biology 1.1k
- Surgery 788
- Molecular Medicine 366
Countries citing papers authored by Melvin Spigelman
This map shows the geographic impact of Melvin Spigelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melvin Spigelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melvin Spigelman more than expected).
Fields of papers citing papers by Melvin Spigelman
This network shows the impact of papers produced by Melvin Spigelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melvin Spigelman. The network helps show where Melvin Spigelman may publish in the future.
Co-authorship network of co-authors of Melvin Spigelman
This figure shows the co-authorship network connecting the top 25 collaborators of Melvin Spigelman. A scholar is included among the top collaborators of Melvin Spigelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melvin Spigelman. Melvin Spigelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed.breakdown → | 167 |
| 2 | 18 | |
| 3 | 0 | |
| 4 | 92 | |
| 5 | 159 | |
| 6 | 50 | |
| 7 | 27 | |
| 8 | 28 | |
| 9 | Tuberculosisbreakdown → | 814 |
| 10 | 184 | |
| 11 | 328 | |
| 12 | 49 | |
| 13 | 53 | |
| 14 | 131 | |
| 15 | 219 | |
| 16 | 40 | |
| 17 | 4 | |
| 18 | 23 | |
| 19 | 9 | |
| 20 | 11 |
About Melvin Spigelman
Melvin Spigelman is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Molecular Medicine, having authored 43 papers that have together received 3.8k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (22 papers), Mycobacterium research and diagnosis (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). The work is most often cited by research in Infectious Diseases (2.6k citations), Molecular Medicine (366 citations) and Applied Microbiology and Biotechnology (105 citations). Melvin Spigelman has collaborated with scholars based in United States, United Kingdom and South Africa. Frequent co-authors include Ann M. Ginsberg, Carl M. Mendel, Christo van Niekerk, Daniel E. Everitt, Keertan Dheda, Mario Raviǵlione, Marcel A. Behr, Haileyesus Getahun, David W. Dowdy and Maziar Divangahi. Their work appears in journals such as New England Journal of Medicine, The Lancet and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.